153 related articles for article (PubMed ID: 21328377)
1. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
Chatterjee K; Williamson AL; Hoffman M; Dandara C
J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
[TBL] [Abstract][Full Text] [Related]
2. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
[TBL] [Abstract][Full Text] [Related]
3. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
Zhang F; Yang Y; Guo C; Wang Y
Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
[TBL] [Abstract][Full Text] [Related]
4. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
5. TP53 polymorphism, HPV infection, and risk of cervical cancer.
Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
[TBL] [Abstract][Full Text] [Related]
6. The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa.
Chattopadhyay K; Williamson AL; Hazra A; Dandara C
BMC Cancer; 2015 Oct; 15():680. PubMed ID: 26458812
[TBL] [Abstract][Full Text] [Related]
7. Functional variants in cell death pathway genes and risk of pancreatic cancer.
Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
[TBL] [Abstract][Full Text] [Related]
8. Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk.
Inserra P; Abrahamsen M; Papenfuss M; Giuliano AR
Int J STD AIDS; 2003 Dec; 14(12):800-4. PubMed ID: 14678586
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women.
Lee SA; Kim JW; Roh JW; Choi JY; Lee KM; Yoo KY; Song YS; Kang D
Gynecol Oncol; 2004 Apr; 93(1):14-8. PubMed ID: 15047208
[TBL] [Abstract][Full Text] [Related]
10. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
[TBL] [Abstract][Full Text] [Related]
11. Impact of polymorphism in IL-1RA gene on the risk of cervical cancer.
Tamandani DM; Sobti RC; Shekari M; Kaur S; Huria A
Arch Gynecol Obstet; 2008 Jun; 277(6):527-33. PubMed ID: 18008080
[TBL] [Abstract][Full Text] [Related]
12. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
Chatterjee K; Dandara C; Hoffman M; Williamson AL
BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
14. MBL2 gene polymorphisms are correlated with high-risk human papillomavirus infection but not with human papillomavirus-related cervical cancer.
Segat L; Crovella S; Comar M; Milanese M; Zanotta N; Fabris A; Trevisiol C; Rossi T; De Seta F; Campello C
Hum Immunol; 2009 Jun; 70(6):436-9. PubMed ID: 19275921
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women.
Su TH; Chang TY; Lee YJ; Chen CK; Liu HF; Chu CC; Lin M; Wang PT; Huang WC; Chen TC; Yang YC
Carcinogenesis; 2007 Jun; 28(6):1237-40. PubMed ID: 17341658
[TBL] [Abstract][Full Text] [Related]
16. Characterization of common and rare human papillomaviruses in Portuguese women by the polymerase chain reaction, restriction fragment length polymorphism and sequencing.
Nobre RJ; Cruz E; Real O; de Almeida LP; Martins TC
J Med Virol; 2010 May; 82(6):1024-32. PubMed ID: 20419818
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of human papillomavirus type 58 in patients with cervical pre-malignant lesions in southern Brazil.
Paesi S; Serafini EP; Barea F; Madi SR; Echeverrigaray S
J Med Virol; 2009 Jul; 81(7):1270-5. PubMed ID: 19475616
[TBL] [Abstract][Full Text] [Related]
18. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
[TBL] [Abstract][Full Text] [Related]
19. Exposure to wood smoke, HPV infection, and genetic susceptibility for cervical neoplasia among women in Colombia.
Sierra-Torres CH; Arboleda-Moreno YY; Orejuela-Aristizabal L
Environ Mol Mutagen; 2006 Aug; 47(7):553-61. PubMed ID: 16795085
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism.
Catarino R; Matos A; Pinto D; Pereira D; Craveiro R; Vasconcelos A; Lopes C; Medeiros R
Cancer Genet Cytogenet; 2005 Jul; 160(1):49-54. PubMed ID: 15949570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
